Viewing Study NCT04586335


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT04586335
Status: TERMINATED
Last Update Posted: 2024-03-21
First Post: 2020-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Sponsor: Haihe Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module